Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosisHannes Vietzen, Elisabeth Puchhammer‐Stöckl, S. Berger et al.|Cell|2023Cited by 170
De-escalating and discontinuing disease-modifying therapies in multiple sclerosisG. Androdias, Bruno Stankoff, Jan D. Lünemann et al.|Brain|2024Cited by 27
Early identification of individuals at risk for multiple sclerosis by quantification of EBNA-1381-452-specific antibody titersHannes Vietzen, Elisabeth Puchhammer-Stöckl, Markus Reindl et al.|Nature Communications|2025Cited by 16
Accumulation of Epstein-Barr virus–induced cross-reactive immune responses is associated with multiple sclerosisHannes Vietzen, Elisabeth Puchhammer‐Stöckl, Laura M. Kühner et al.|Journal of Clinical Investigation|2024Cited by 15
Accumulation and Ineffective Immune Control of Epstein-Barr Virus-Induced Cross-Reactive Immune Responses is associated with Multiple Sclerosis 9114Hannes Vietzen, Elisabeth Puchhammer-Stoeckl, Laura M. Khner et al.|The Journal of Immunology|2025Cited by 0